Thermage vs Volnewmer: Comparing Two Radiofrequency Devices

If you are deciding between Thermage FLX and Volnewmer, the device name alone will not tell you which to choose. Both use externally applied monopolar radiofrequency energy to address skin appearance without needles, but their cooling systems and application techniques differ. A small direct study found broadly similar short-term changes in several facial measures and lower pain scores with Volnewmer under the protocol tested. It cannot establish that either device is best for every woman or that results last equally long. Begin with your goal, skin condition and tolerance for discomfort, not the brand.

Perhaps you want a subtly firmer area under the chin without changing how you look. Or perhaps you hope for a dramatic lift of noticeably descended tissues. Non-invasive RF may be worth discussing in the first case; in the second, neither Thermage FLX nor Volnewmer can replace surgical repositioning of tissues. The general principles are covered in our guide to non-invasive RF skin tightening. Here we focus on differences that actually matter when choosing between these models.

Where the devices differ—and what has not been proven

Question	Thermage FLX	Volnewmer
Principle	Monopolar RF with an external treatment tip; no needles	6.78 MHz monopolar RF with external treatment tips; no needles
Surface protection	Cryogen cooling bursts; vibration is included to improve comfort	Continuous water-based contact cooling; a moving treatment technique is available
What was compared head to head?	In a 2025 study, both devices were used on opposite sides of 22 women's faces, with eight weeks of follow-up
Short-term changes	In this protocol, some lifting, volume and wrinkle measures were comparable; individual response remains unpredictable
Pain during treatment	Pain scores were higher in the small study	Pain scores were lower in the same study; this does not promise pain-free treatment
How long it lasts	Longer observations exist for newer monopolar RF including FLX, but they do not predict an individual result	The direct comparison with FLX did not establish which outcome lasts longer
Risks and reversibility	Thermal injury and changes in skin texture are possible; the effect cannot simply be “undone”	This device also heats tissue; no complications recorded in a small trial does not mean zero risk

“More powerful”, “deeper” and “newer” can sound compelling, but none tells you how much your contour will improve or what thermal exposure tissue undergoes. For devices with similar physical principles, relevant factors include treatment-tip area and shape, contact, cooling, pulse timing and distribution, your anatomy and the trained practitioner's technique. One device's shot count cannot be compared directly with the other's as a measure of quality.

What did the split-face comparison actually show?

A study published in Annals of Dermatology treated one side of the face with Volnewmer and the other with Thermage FLX in 22 women of Asian ancestry. The order of treatment sides was randomised while device assignment to the sides alternated; participants were followed for eight weeks, and researchers used some objective measurements and independent assessment of photographs. Within those conditions they reported comparable improvement in certain lifting, volume and wrinkle measures. Procedural pain scores were statistically lower on the Volnewmer-treated side.

One more qualification matters when reading the trial. Participants were aged 38–50. Some measures, including skin density and pore size, changed more on the Volnewmer side, while several measures of elasticity, lifting and wrinkles were similar between sides. These are individual endpoints in 22 women, not evidence of a visibly superior outcome across all ages and face types.

This is more informative than comparing two advertising galleries. But the sample was small, with a limited age and ancestry mix and short follow-up. Participants received topical anaesthesia, and each device was used under specific settings and techniques. These results cannot show that Volnewmer will always be more comfortable in every practice, that it is better after a year, or that complications cannot occur. The study is not a personalised safety ranking and does not replace an in-person evaluation.

A separate open-label study of a newer monopolar RF generation followed 40 people with mild to moderate face and upper-neck laxity for six months. There are also small Volnewmer studies. Different participants, treatment protocols and outcome measures cannot fairly be combined into a “percentage victory”. If shown a Thermage CPT study, remember that CPT is not FLX. When a Volnewmer study includes extra products or other procedures, its outcome cannot be attributed to the device alone.

If comfort matters most, does the pain study favour Volnewmer?

The eight-week comparison provides grounds to discuss potentially less pain with Volnewmer in that specific protocol, not a guarantee for you. RF sensations range from warmth to intense, painful heating; the area, sensitivity, anaesthesia and settings matter. Thermage FLX's manufacturer lists cooling and vibration for comfort but also notes that pain can occur. Rather than ask “Which is painless?”, ask: “How will you monitor my discomfort, what happens if it becomes intense, and can you safely stop treatment?”

Do not request higher energy simply because the treatment feels comfortable. Equally, you do not need to tolerate increasing pain for a promised “better lift”. Your clinician should explain how contact and heat are controlled, how sensitive sites are protected and which sensations must be reported immediately. Cooling with either method can help protect superficial layers, but it cannot make heating risk-free.

Which concerns could each device address—and when should you choose neither?

Existing evidence cannot reliably assign patients by slogans such as “Thermage after 45, Volnewmer before 45” or “one for necks, one for cheeks”. Those are marketing shortcuts, not proven universal rules. At a consultation, distinguish mild skin laxity from substantial tissue excess, facial volume changes, deep folds visible at rest and expression-related wrinkles. RF may offer mild improvements in firmness and some superficial ageing signs; it does not correct the anatomical cause of every fold.

If a clearly visible outcome by a fixed date is essential, discuss both the limits of change and uncertainty of timing. Photographs taken from one angle do not establish lasting device superiority. If the main concern is pigmentation, inflammatory skin disease or a suspicious lesion, diagnosis should come before choosing a tightening device. With substantial excess skin, a surgeon's opinion may be more useful than a promise from an energy-based procedure. With minimal concerns, sun protection, skincare and observation without intervention are reasonable.

Recovery, safety and changes you cannot quickly reverse

Both systems deliver RF at the skin surface rather than through needles. Most patients therefore need no puncture-site care, and major routine downtime is not expected. But “able to work” is not the same as “no one will notice”: redness, mild swelling, tenderness or an unexpected response may matter before travel or a public appearance. Avoid scheduling directly before important events, particularly if you have reacted unusually to device treatments in the past.

Thermage FLX safety materials describe swelling, redness, bruising, pain, altered sensation, skin surface irregularities and pigmentation changes, burns, blisters and scarring. The direct comparative studies reviewed up to October 2026 do not provide enough data to estimate the frequency of rare complications separately for each platform reliably. Volnewmer also heats tissue, so zero-risk promises are not credible. Blisters, increasing pain, unusual colour changes or marked asymmetry require medical review; rapidly worsening tissue injury requires urgent care. Thermal injury and scarring cannot be instantly dissolved or reversed like some injectable products.

Thermage FLX manufacturer instructions contraindicate pacemakers, defibrillators and other active implanted electrical devices. The manufacturer also notes insufficient study in pregnancy or breastfeeding, over fillers, in certain diseases, and over tattoos or permanent makeup. Do not assume the exact same wording applies to Volnewmer: check the current contraindications and instructions for that specific model instead of copying another brand's list. Tell your clinician about implants, pregnancy or breastfeeding, medical conditions, medication and previous treatments before deciding.

For treatment within the bony orbital rim, the manufacturer requires plastic protective eye shields. Vibration must not be used while they are in place because the shields can shift and injure the eye. Eye pain or a change in vision after treatment requires urgent medical assessment.

FDA “approval”: why the precise indication matters

US manufacturer documentation for Thermage FLX includes indications for non-invasive treatment of wrinkles, including around the eyes. The first Volnewmer 510(k) decision identified in the FDA database is K240248, dated 29 April 2024, for electrocoagulation and haemostasis (control of bleeding) of soft tissue in dermatologic procedures. A subsequent decision, K253504, dated 13 July 2026, retains that intended use: compared with K240248, its principal stated change was a software-controlled repeat-pulse mode. Neither decision alone establishes a separate FDA indication for aesthetic skin lifting with Volnewmer or proves equal clinical effectiveness of the two devices. A substantial-equivalence decision under 510(k) is not a separate FDA premarket approval (PMA). US status does not establish whether a particular device is available, registered or permitted for use in Armenia; this must be checked locally before treatment.

Questions that conclude the comparison better than a sales chart

For either choice, ask the practitioner to explain the specific goal for your skin, why a particular tip and treatment area were selected, what the research does not establish, what your appearance may be like over the next few days and when to assess the result. Clarify who checks contraindications in person, ensures eye protection for periocular treatment, documents adverse reactions and provides help if something goes wrong. A quote should itemise the area, consumables, procedure, review visits and potential extra charges; without verified local prices neither device can be labelled the cheaper choice.

If a practice offers only one of these devices, ask why it fits your concern without denigrating the alternative. If anyone promises dramatic lifting for all or a long-term guarantee without supporting evidence, consider another opinion. You can also defer both treatments if the risk, cost or probable magnitude of change does not feel worthwhile. For image analysis see Thermage FLX before and after; for patients' experiences read how to interpret Thermage FLX reviews. The best choice is the one whose potential modest benefit justifies its discomfort and uncertainty for you, not the one with the loudest branding.

Additional questions

Would using both devices one after another give a stronger effect?

There is no reliable basis for assuming that combination is automatically more effective or safer. Do not schedule two heat-based procedures yourself; a clinician should justify any combination and its intervals after assessing your skin and previous treatments.